The federal contract award AG7D28P150032 was issued by the Plains Area division of the U.S. Department of Health and Human Services to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and peptide-based products. The $9,758.50 firm fixed price purchase order is for the delivery of PEPSTAR PEPTIDE MICROARRAY PEPTIDES and does not have a set-aside designation. JPT Peptide Technologies has previously received over $250,000 in federal contract awards from...
This federal contract award, identified as HHSN272201500430P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to the prime contractor Atlantic Peptides LLC. The contract is for the purchase of a set of 30 peptides, each at 1 milligram and 75% purity, for a fixed price of $3,900.00. The contract has a completion date of April 3, 2015 and was awarded on March 4, 2015. No set-aside designation is...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract worth $248,887.50 to Boston Bioscience Inc., a for-profit organization, for the synthesis of COVID-19 related proteins. The contract was awarded on a sole-source basis, without a set-aside, to support the Vaccine Research Center's efforts in analyzing immune responses to SARS-CoV-2 infection and vaccination. The...
This federal contract award was issued by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and peptide-based products. The $4,652 firm fixed price purchase order supports the provision of peptide mixtures, reagents, assay kits, and testing services related to cancer, COVID-19, allergies, and infectious disease research. JPT has received over $250,000...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of custom peptides and related research products. The $3,620 firm fixed price purchase order is for the delivery of peptide microarrays displaying peptides from a previous order, in support of NIAID's research activities. The award has no set-aside...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $29.9 million delivery order to Protein Sciences Corporation under the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The delivery order is for non-clinical and Phase I clinical studies of a stabilized pre-fusion trimer of the spike protein COVID-19 vaccine candidate reconstituted with two adjuvants, AS03 and AF03, to be performed in Meriden,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Vivitide LLC, a manufacturer of laboratory supplies and custom peptides. The $32,500 firm fixed price contract is for the provision of peptide libraries, catalog-listed as "TIER ONE FLASHPURE," to support drug discovery and development activities. This award does not utilize any set-aside designation. Vivitide...
Polypeptide Laboratories San Diego, LLC, doing business as Polypeptide Labs, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the National Institutes of Health's National Institute on Drug Abuse. The $598,190 delivery order is for the synthesis and distribution of opioid and related peptides over the one year period of performance from February 15, 2024 through February 14, 2025. The underlying indefinite delivery contract, awarded in 2022...
In September 2023, the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $389.4 million cost-plus-fixed-fee contract to Codagenix Inc., a clinical-stage biotechnology company. The contract is for Codagenix to conduct a Phase 2B efficacy study of its proprietary live attenuated COVID-19 vaccine candidate, Coviliv, which utilizes the company's Synthetic Attenuated Virus Engineering (SAVE) technology. This contract was not...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to JPT Peptide Technologies GMBH, a foreign-owned for-profit manufacturer of goods. The $7,110 firm fixed price purchase order is for the delivery of "MAXI SPIKETIDES", which appears to be a product or service related to the agency's research efforts in areas such as cancer, COVID-19, allergies, and infectious diseases. The...